[Evaluation of the effectiveness and tolerance of the preparation Craviten].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005029:Ethylenediamines / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged
D005029:Ethylenediamines; C030706:butobendin
Ocena skuteczności i tolerancji preparatu Craviten.